Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Acute Pain Crisis in Sickle Cell Disease
NCT00252122Phase 4Terminated
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Jun 2004
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in sickle cell disease (SCD), sponsored by Children's Hospital of Philadelphia. Started Jun 2004; status: terminated.
02
Drugs
ketamine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT00252122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252122.